The Endocrine Tumor and Bone research program at the Saint John’s Cancer Institute is focused on improving the detection and treatment of endocrine tumors and bone disorders with an improved quality of life and survivorship.

The team is led by a pioneer in the field of bone metabolism, osteoporosis, and parathyroid disease, Dr. Fred Singer, and by Dr. Melanie Goldfarb, an endocrine surgeon and recognized expert in  thyroid cancer disparities, survivorship, thyroid ultrasound, and pediatric / young adult thyroid cancer. In addition to health services and outcomes research with large cancer databases, they work alongside translational and basic researchers and with their surgical fellows to advance the endocrine field and can quickly translate their findings to the bedside.

This includes clinical and translational research projects for thyroid cancer, thyroid nodules, pediatric and young adult thyroid cancer, thyroid cancer survivorship, quality of life, secondary thyroid cancer and screening, thyroid ultrasound, cancer disparities, hyperparathyroidism, 4D parathyroid CT, vitamin D deficiency, osteoporosis, Pagets disease, fibrous dysplasia, inherited endocrine neoplasias, adrenal incidentalomas, adrenal cancer, pheochromocytoma, Cushings syndrome.